Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Post-prostatectomy radiotherapy: for which patients and when?].

C Hennequin1, V Ravery, C Maylin

  • 1Service de cancérologie-radiothérapie, hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France. christophe.hennequin@sls.ap-hop-paris.fr

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|July 16, 2002
PubMed
Summary

Adjuvant radiotherapy after prostatectomy may benefit select patients with high-risk features like extensive extracapsular extension. Delayed salvage radiotherapy can lower PSA levels but requires close monitoring for long-term effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trichophyton mentagrophytes ITS genotype VII infections among men who have sex with men in France: An ongoing phenomenon.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

[Informed consent in radiotherapy care].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Same author

Current knowledge and practice of Candida auris screening in France: A nationwide survey from the French Society of Medical Mycology (SFMM).

Journal de mycologie medicale·2024
Same author

[Antimicrobial peptides: A new alternative for the treatment of aspergillosis].

Revue des maladies respiratoires·2024
Same author

Withdrawal notice to "Changes in the fungal nomenclature: why and how to manage?" [J Mycol Med 33 (2023) 101387].

Journal de mycologie medicale·2023
Same author

[Targeted systemic treatments and locoregional radiotherapy for breast cancer: Can we expect a benefit from the potentiation of local treatment?]

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023

Area of Science:

  • Urology
  • Radiation Oncology
  • Oncology

Context:

  • Biochemical relapse occurs in 10-40% of patients post-radical prostatectomy.
  • Adjuvant radiotherapy is considered for high-risk patients to prevent relapse.
  • Evidence from Phase III trials is lacking for routine adjuvant radiotherapy.

Purpose:

  • To evaluate the efficacy of adjuvant and salvage radiotherapy in managing biochemical relapse after radical prostatectomy.
  • To identify optimal patient selection criteria for adjuvant and delayed radiotherapy.
  • To compare outcomes of immediate adjuvant irradiation versus observation and delayed salvage treatment.

Summary:

  • Adjuvant radiotherapy appears beneficial for patients with extensive extracapsular extension or multiple positive surgical margins, based on historical comparisons.

Related Experiment Videos

  • Delayed (salvage) radiotherapy can reduce prostate-specific antigen (PSA) levels in 40-70% of cases.
  • Long-term efficacy of salvage radiotherapy is contingent on pre-treatment PSA levels and necessitates close patient follow-up.

    • Impact:

    • This analysis aids in refining treatment strategies for prostate cancer recurrence.
    • It highlights the importance of patient selection for radiotherapy to maximize biochemical control.
    • Understanding relapse patterns (local vs. distant) based on surgical findings like positive nodes or seminal vesicle involvement is crucial for prognosis.